The licensing of medicine by America's Food and Drug Administration has become slower since 2004 when a pain-killer, Vioxx, was withdrawn by its maker, Merck, because it increased the risk of heart attacks and strokes.
ECONOMIST: America, Europe and the management of danger: A hazardous comparison | The